Ceske Budejovice, Czechia

Vladimir Matha

This inventor holds 3 USPTO granted patents. Top assignee: Galena as. Active years: 2000-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladimir Matha. Retrieved from https://idiyas.com/inventor/vladimir-matha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Vladimir Matha

Introduction

Vladimir Matha is a notable inventor based in Ceske Budejovice, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance the bioavailability of active ingredients.

Latest Patents

Vladimir Matha holds 3 patents, with his latest inventions focusing on immunomodulatory pharmaceutical compositions. One of his notable patents is for a formulation that adopts lyotrophic liquid crystals when in contact with an aqueous phase. This includes a cyclosporin formulation that allows for therapeutic compositions with high bioavailability, enabling concentrations in dosage forms greater than 10%.

Career Highlights

Vladimir Matha has established himself as a key figure in pharmaceutical innovation. His work has led to advancements that improve the effectiveness of therapeutic treatments, particularly in the area of immunomodulation.

Collaborations

He collaborates with esteemed colleagues such as Milan Stuchlik and Ales Husek, contributing to a dynamic research environment that fosters innovation.

Conclusion

Vladimir Matha's contributions to pharmaceutical science through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of effective therapeutic compositions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…